Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Paclitaxel × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 37 Breast Neoplasms 25 Lung Neoplasms 15 Ovarian Neoplasms 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Triple Negative Breast Neoplasms 11 Endometrial Neoplasms 11 Fallopian Tube Neoplasms 10 Neoplasm Metastasis 9 Squamous Cell Carcinoma of Head and Neck 8 Neoplasms 8 Esophageal Neoplasms 6 Colorectal Neoplasms 6 Carcinoma 6 Stomach Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Small Cell Lung Carcinoma 4 Head and Neck Neoplasms 4 Adenocarcinoma Of Esophagus 4 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Rectal Neoplasms 2 Pathologic Complete Response 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2

Interventions

Specimen Handling 3 Magnetic Resonance Spectroscopy 3 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 cabozantinib 1 belzutifan 1 atezolizumab 1 X-Rays 1 Temozolomide 1 Sunitinib 1 Phantoms, Imaging 1 LY2940680 1 Interleukin-13 1 Immunoglobulin G 1 Fluorodeoxyglucose F18 1 Everolimus 1 Disulfides 1 Cyclophosphamide 1 Capecitabine 1 Biopsy 1 Bevacizumab 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡